NIDC News
Our NIDC News reports the latest developments in U.S. Department of Energy’s isotope production efforts, university partnerships, facility improvements, staff news, and other notable center activities as they occur. Stay Connected
October 7, 2022
The DOE IP invites you to join us for virtual "one-on-one" stakeholder meetings on Nov. 1, Nov. 17 and Nov. 21, 2022.
These meetings offer an excellent opportunity for companies and institutions to discuss isotope supply and demand issues firsthand with the federal DOE IP Director and Program Managers and the NIDC staff from Oak Ridge National Laboratory. We are looking forward…
August 22, 2022
Targeted radiation therapy may provide an alternative in treating some blood-borne cancers
The University of Washington and Fred Hutchinson Cancer Center produce and deliver unique cancer therapy for clinical trials.
While no two cancers are the same and every patient reacts differently to treatment, scientists in the Departments of Radiation…
August 5, 2022
The Office of Science is pleased to announce that applications are currently being accepted for the Spring 2023 term for three programs offered by the U.S. Department of Energy (DOE) Office of Science: the Science Undergraduate Laboratory Internships (SULI) program, the Community College Internships (CCI) program, and the Visiting Faculty Program (VFP).
SULI and CCI offer…
July 1, 2022
Cathy Sue Cutler, PhD, FSNMMI, Director of the Medical Isotope Research and Production Program (MIRP) at Brookhaven National Laboratory, has been named as Vice President-elect for the Society of Nuclear Medicine and Molecular Imaging (SNMMI).The MIRP is a key production site in the DOE Isotope Program and Dr. Cutler is a world leader in the development and production of isotopes.
Dr. Cutler…
May 12, 2022
With current world events in play, the U.S. Department of Energy Isotope Program has been carefully monitoring global radio- and stable isotope supply chains and have put mitigation plans in place.
If you are having trouble obtaining isotopes, including Ac-225, Am-241, Ba-133, C-14, Cd-109, Ce-139, Cf-252, Co-57, Cs-131, Cs-137, Fe-55, Fe-59, Ge-68, Gd-153, He-3, Ir-192, Kr-85, Mn-54, Ni-63, P-…
May 9, 2022
The US Department of Energy Office of Isotope R&D and Production (DOE IP) is pleased to invite representatives from US Minority Serving Institutions to a virtual townhall discussion to discuss planned funding opportunities related to undergraduate and graduate workforce development and R&D in isotope science. Academic institutions with programs or interests in physics, chemistry,…
April 12, 2022
These meetings offer an excellent opportunity for companies and institutions to discuss isotope supply and demand firsthand with the federal DOE IP director, federal DOE program managers, and the NIDC staff. We are looking forward to insightful discussions with the aim to better serve the isotope community through a clearer understanding of stakeholder needs and concerns.
If you are…
April 11, 2022
Earlier this week, the U.S. Department of Energy (DOE) announced $1 million in funding for three awards to advance research and development (R&D) to translate newly developed radioisotopes into evaluation for potential use in preclinical and clinical trials. This funding is part of a key federal program that produces critical isotopes otherwise unavailable or in short supply…
February 16, 2022
The SCGSR program supports awards to outstanding U.S. graduate students to conduct part of their graduate thesis research at a DOE national laboratory or host site in collaboration with a DOE laboratory scientist — with the goal of preparing graduate students for scientific and technical careers critically important to the DOE Office of Science mission. The research opportunity is expected…
December 14, 2021
In experiment after experiment, the synthetic radioisotope actinium-225 has shown promise for targeting and attacking certain types of cancer cells.
Although researchers have studied this radioisotope’s cancer-fighting potential for more than two decades, there’s not a Food and Drug Administration-approved treatment using Ac-225 — yet. But with more Ac-225 available from the DOE Isotope…
